Odyssey Health (ODYY) Provides Update on Asset Purchase Agreement with Oragenics (OGEN) Oct 18, 2023 08:34AM
Odyssey Health, Inc. Provides Update on Asset Purchase Agreement with Oragenics, Inc. Oct 18, 2023 08:30AM
Oragenics (OGEN) to Acquire Odyssey Health’s (ODYY) Neurological Drug Technology Pipeline Including Concussion Drug Candidate Oct 5, 2023 06:30AM
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate Oct 5, 2023 06:30AM
Oragenics Project to Develop a Variant-Agnostic Protein Antigen for Use in its COVID-19 Intranasal Vaccine Receives Funding from CQDM Jun 5, 2023 04:18PM


Mar 2, 2020 04:05PM Precigen Reports Fourth Quarter and Year End 2019 Financial Results
Nov 12, 2019 07:30AM Intrexon Reports Third Quarter 2019 Financial Results
Nov 8, 2018 04:10PM Intrexon Announces Third Quarter 2018 Financial Results
Nov 9, 2017 04:05PM Intrexon Announces Third Quarter 2017 Financial Results
Mar 1, 2017 05:10PM Intrexon Announces Fourth Quarter and Full Year 2016 Financial Results
Nov 9, 2016 04:05PM Intrexon Announces Third Quarter 2016 Financial Results
Jun 6, 2016 04:56PM Oragenics (OGEN) Names Alan Joslyn as President, CEO
Jun 6, 2016 04:51PM Oragenics Announces new President, Chief Executive Officer and Member of the Board of Directors
Jul 17, 2015 08:45AM Oragenics Shareholders Re-elect Existing Board of Directors; Approve and Ratify other Proposals